nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
About the Esteve Foundation
|
|
|
2005 |
1277 |
C |
p. v- 1 p. |
artikel |
2 |
Application, efficiency and cargo-dependence of transport peptides
|
Langedijk, J.P.M. |
|
2005 |
1277 |
C |
p. 95-107 13 p. |
artikel |
3 |
Application of nanoparticles for the delivery of drugs to the brain
|
Kreuter, Jörg |
|
2005 |
1277 |
C |
p. 85-94 10 p. |
artikel |
4 |
Author index
|
|
|
2005 |
1277 |
C |
p. 265- 1 p. |
artikel |
5 |
Carrier-mediated transport to enhance drug delivery to brain
|
Smith, Quentin R. |
|
2005 |
1277 |
C |
p. 63-74 12 p. |
artikel |
6 |
Contents
|
|
|
2005 |
1277 |
C |
p. xiii-xv nvt p. |
artikel |
7 |
Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood–brain barrier
|
Gabathuler, Reinhard |
|
2005 |
1277 |
C |
p. 171-184 14 p. |
artikel |
8 |
Diphtheria toxin receptor-targeted brain drug delivery
|
Gaillard, Pieter J. |
|
2005 |
1277 |
C |
p. 185-198 14 p. |
artikel |
9 |
Disclaimer
|
|
|
2005 |
1277 |
C |
p. vi- 1 p. |
artikel |
10 |
Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems
|
Pardridge, William M. |
|
2005 |
1277 |
C |
p. 49-62 14 p. |
artikel |
11 |
Editorial Board
|
|
|
2005 |
1277 |
C |
p. iii- 1 p. |
artikel |
12 |
Efflux transport systems at the blood–brain barrier and blood CSF barrier
|
Kusuhara, Hiroyuki |
|
2005 |
1277 |
C |
p. 111-122 12 p. |
artikel |
13 |
Experimental models to evaluate the role of P-glycoprotein in the blood–brain tumor barrier
|
van Tellingen, Olaf |
|
2005 |
1277 |
C |
p. 123-130 8 p. |
artikel |
14 |
Final discussion
|
de Boer, Albertus G. |
|
2005 |
1277 |
C |
p. 257-260 4 p. |
artikel |
15 |
Group photo
|
|
|
2005 |
1277 |
C |
p. vii- 1 p. |
artikel |
16 |
Influx transporters and drug targeting: Application of peptide and cation transporters
|
Tsuji, Akira |
|
2005 |
1277 |
C |
p. 75-84 10 p. |
artikel |
17 |
Introduction
|
Gerrit de Boer, Albertus |
|
2005 |
1277 |
C |
p. xi- 1 p. |
artikel |
18 |
Introduction & Acknowledgements
|
|
|
2005 |
1277 |
C |
p. viii- 1 p. |
artikel |
19 |
Keyword index
|
|
|
2005 |
1277 |
C |
p. 267-268 2 p. |
artikel |
20 |
List of participants
|
|
|
2005 |
1277 |
C |
p. ix-x nvt p. |
artikel |
21 |
Novel opportunities for the treatment of brain diseases
|
de Boer, Albertus G. |
|
2005 |
1277 |
C |
p. 261-264 4 p. |
artikel |
22 |
Overcoming MDR at the blood–brain barrier
|
Fricker, Gert |
|
2005 |
1277 |
C |
p. 131-143 13 p. |
artikel |
23 |
Physiology of the blood–brain barrier and its consequences for drug transport to the brain
|
Abbott, N. Joan |
|
2005 |
1277 |
C |
p. 3-18 16 p. |
artikel |
24 |
Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by RNA interference
|
Lage, Hermann |
|
2005 |
1277 |
C |
p. 144-153 10 p. |
artikel |
25 |
Single domain antibodies as blood–brain barrier delivery vectors
|
Abulrob, Abedelnasser |
|
2005 |
1277 |
C |
p. 212-223 12 p. |
artikel |
26 |
The blood–brain barrier and treatment of lysosomal storage diseases
|
Aerts, J.M. |
|
2005 |
1277 |
C |
p. 19-31 13 p. |
artikel |
27 |
The blood–brain barrier in diabetes mellitus: A critical review of clinical and experimental findings
|
Tolia, Evangelia |
|
2005 |
1277 |
C |
p. 244-256 13 p. |
artikel |
28 |
The blood–brain barrier in multiple sclerosis
|
McQuaid, S. |
|
2005 |
1277 |
C |
p. 235-243 9 p. |
artikel |
29 |
The blood–brain barrier in trauma, stroke and edema
|
Verlooy, Jan |
|
2005 |
1277 |
C |
p. 227-234 8 p. |
artikel |
30 |
The multidrug resistance protein BMDP/ABCG2: A new and highly relevant efflux pump at the blood–brain barrier
|
Drees, Anja |
|
2005 |
1277 |
C |
p. 154-168 15 p. |
artikel |
31 |
The priorities/needs of the pharmaceutical industry in drug delivery to the brain
|
Lemaire, Michel |
|
2005 |
1277 |
C |
p. 32-46 15 p. |
artikel |
32 |
The use of Pep: Trans vectors for the delivery of drugs into the central nervous system
|
Scherrmann, Jean-Michel |
|
2005 |
1277 |
C |
p. 199-211 13 p. |
artikel |